Trial Profile
The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2022
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease; Cognition disorders; Neurodegenerative disorders
- Focus Diagnostic use
- 22 Dec 2022 Status changed from recruiting to discontinued.
- 26 Mar 2014 New trial record